Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Zarowitz

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Pharmacotherapy|January 1, 1990
Relationship between values of bioelectrical impedance and creatinine clearanceM A Smythe, T J Baumann, B J Zarowitz, et al.
Progress in Cardiovascular Diseases|September 1, 1995
Electrophysiologic and proarrhythmic effects of intravenous inotropic agentsJ E Tisdale, R Patel, C R Webb, et al.
Journal of Clinical Pharmacology|June 1, 1993
Determination of gentamicin pharmacokinetics by bioelectrical impedance in critically ill adultsB J Zarowitz, S Robert, M Mlynarek, et al.
Pharmacotherapy|March 1, 1996
Bar code documentation of pharmacotherapy services in intensive care unitsB J Zarowitz, A Petitta, M I Rudis, et al.
The American Journal of Clinical Nutrition|June 1, 1993
Bioelectrical impedance assessment of nutritional status in critically ill patientsS Robert, B J Zarowitz, R Hyzy, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1995
Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal diseaseM A Touchette, R V Patel, J V Anandan, et al.
DICP : the Annals of Pharmacotherapy|June 1, 1990
Bioimpedance assessment of antipyrine pharmacokinetics before and after enzyme inductionA M Pilla, B J Zarowitz, C K Svensson, et al.
The Annals of Pharmacotherapy|March 1, 1995
Proarrhythmic effects of intravenous vasopressorsJ E Tisdale, R V Patel, C R Webb, et al.
Developmental Pharmacology and Therapeutics|January 1, 1984
The pharmacokinetics and metabolism of cimetidine in neonatesJ A Ziemniak, R J Wynn, J V Aranda, et al.
Pharmacotherapy|July 1, 1996
Critical pathways: the time is here for pharmacist involvement. American College of Clinical PharmacyJ K Kirk, K A Michael, S J Markowsky, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Pharmacotherapy|January 1, 1990
Relationship between values of bioelectrical impedance and creatinine clearanceM A Smythe, T J Baumann, B J Zarowitz, et al.
Progress in Cardiovascular Diseases|September 1, 1995
Electrophysiologic and proarrhythmic effects of intravenous inotropic agentsJ E Tisdale, R Patel, C R Webb, et al.
Journal of Clinical Pharmacology|June 1, 1993
Determination of gentamicin pharmacokinetics by bioelectrical impedance in critically ill adultsB J Zarowitz, S Robert, M Mlynarek, et al.
Pharmacotherapy|March 1, 1996
Bar code documentation of pharmacotherapy services in intensive care unitsB J Zarowitz, A Petitta, M I Rudis, et al.
The American Journal of Clinical Nutrition|June 1, 1993
Bioelectrical impedance assessment of nutritional status in critically ill patientsS Robert, B J Zarowitz, R Hyzy, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1995
Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal diseaseM A Touchette, R V Patel, J V Anandan, et al.
DICP : the Annals of Pharmacotherapy|June 1, 1990
Bioimpedance assessment of antipyrine pharmacokinetics before and after enzyme inductionA M Pilla, B J Zarowitz, C K Svensson, et al.
The Annals of Pharmacotherapy|March 1, 1995
Proarrhythmic effects of intravenous vasopressorsJ E Tisdale, R V Patel, C R Webb, et al.
Developmental Pharmacology and Therapeutics|January 1, 1984
The pharmacokinetics and metabolism of cimetidine in neonatesJ A Ziemniak, R J Wynn, J V Aranda, et al.
Pharmacotherapy|July 1, 1996
Critical pathways: the time is here for pharmacist involvement. American College of Clinical PharmacyJ K Kirk, K A Michael, S J Markowsky, et al.
Pageof 8